NOL6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.030400E-01
Normal-vs-Stage2
7.518400E-01
Normal-vs-Stage3
1.003050E-01
Normal-vs-Stage4
5.537000E-01
Stage1-vs-Stage2
8.486800E-01
Stage1-vs-Stage3
6.575500E-02
Stage1-vs-Stage4
7.525200E-01
Stage2-vs-Stage3
1.119760E-01
Stage2-vs-Stage4
9.482400E-01
Stage3-vs-Stage4
1.074630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.398400E-01
Normal-vs-AfricanAmerican
9.276200E-01
Normal-vs-Asian
6.404000E-01
Caucasian-vs-AfricanAmerican
5.385000E-01
Caucasian-vs-Asian
9.734000E-01
AfricanAmerican-vs-Asian
5.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.812000E-01
Normal-vs-Female
6.967600E-01
Male-vs-Female
6.632200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.423400E-01
Normal-vs-Age(41-60Yrs)
7.807200E-01
Normal-vs-Age(61-80Yrs)
7.434600E-01
Normal-vs-Age(81-100Yrs)
6.447800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.359200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.660200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.835600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.689000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.130600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.309600E-01
Normal-vs-Daily Drinker
8.964000E-01
Normal-vs-Weekly Drinker
7.996400E-01
Normal-vs-Occasional Drinker
6.523000E-01
Normal-vs-Social Drinker
6.957800E-01
Non Drinker-vs-Daily Drinker
6.536400E-02
Non Drinker-vs-Weekly Drinker
1.374350E-02
Non Drinker-vs-Occasional Drinker
1.463550E-01
Non Drinker-vs-Social Drinker
5.776600E-03
Daily Drinker-vs-Weekly Drinker
5.013800E-01
Daily Drinker-vs-Occasional Drinker
6.536600E-01
Daily Drinker-vs-Social Drinker
3.462600E-01
Weekly Drinker-vs-Occasional Drinker
2.483800E-01
Weekly Drinker-vs-Social Drinker
8.060600E-01
Occasional Drinker-vs-Social Drinker
1.540810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.545800E-01
Normal-vs-Grade 2
9.127000E-01
Normal-vs-Grade 3
9.021400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.581800E-01
Grade 1-vs-Grade 3
4.881400E-01
Grade 1-vs-Grade 4
9.545800E-01
Grade 2-vs-Grade 3
8.295600E-01
Grade 2-vs-Grade 4
9.127000E-01
Grade 3-vs-Grade 4
9.021400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.735400E-01
Normal-vs-NonDiabetic
7.453200E-01
Diabetic-vs-NonDiabetic
3.529000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.918200E-01
Normal-vs-NoPancreatitis
6.946400E-01
Pancreatitis-vs-NoPancreatitis
7.053200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.306800E-01
Normal-vs-N1
7.610400E-01
N0-vs-N1
9.698000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.425200E-01
Normal-vs-TP53-NonMutant
9.149800E-01
TP53-Mutant-vs-TP53-NonMutant
5.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
